Orion Oyj Logo

Orion Oyj

ORNAV | HE

Overview

Corporate Details

ISIN(s):
FI0009014377 (+1 more)
LEI:
74370029VAHCXDR7B745
Country:
Finland
Address:
Orionintie 1, FI-02200 ESPOO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs). The company's research and development activities are focused on translating science into novel therapies, with a primary emphasis on oncology and pain management. Its product portfolio includes proprietary prescription drugs, generic medications, and over-the-counter (OTC) products. With over a century of experience, Orion is dedicated to 'building well-being' by developing innovative treatments and diagnostic tests for a global market.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Orion Oyj. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 08:00
Share Issue/Capital Change
337 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-08-20 08:00
Share Issue/Capital Change
337,000 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-08-08 08:30
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Juhani Kankaanpää
Finnish 4.9 KB
2025-08-08 08:30
Director's Dealing
Orion Corporation: Managers' transactions - Juhani Kankaanpää
English 4.8 KB
2025-08-04 15:10
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Satu Ahomäki
Finnish 3.5 KB
2025-08-04 15:10
Director's Dealing
Orion Corporation: Managers' transactions - Satu Ahomäki
English 3.5 KB
2025-07-18 11:00
Interim Report
Orion-konsernin puolivuosikatsaus tammi-kesäkuu 2025
Finnish 18.4 KB
2025-07-18 11:00
Earnings Release
Orion Group Half-Year Financial Report January-June 2025
English 18.3 KB
2025-07-18 08:30
Report Publication Announcement
Orion-konsernin tulosjulkistukset ja yhtiökokous vuonna 2026
Finnish 3.4 KB
2025-07-18 08:30
Report Publication Announcement
Orion Corporation's financial reporting and Annual General Meeting in 2026
English 3.6 KB
2025-07-09 12:00
Management Discussion and Analysis
Sisäpiiritieto: Orion parantaa näkymäarviota vuodelle 2025
Finnish 3.5 KB
2025-07-09 12:00
Earnings Release
Inside information: Orion upgrades full-year outlook for 2025
English 3.6 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141 959 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141,959 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-05-08 14:30
Major Shareholding Notification
Orion Corporation: Disclosure Under..
Finnish 5.6 KB

Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Orion Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Specialty vaccine developer for travelers and infectious diseases like chikungunya.
France VLA
VENTURE LIFE GROUP PLC Logo
Develops and distributes consumer self-care products for the ageing population worldwide.
United Kingdom VLG
Vetoquinol SA Logo
Develops and distributes veterinary drugs and products for livestock and companion animals globally.
France VETO
Vifor Pharma AG Logo
Develops iron-based pharmaceuticals for iron deficiency, nephrology, and rare diseases.
Switzerland VIFN
Virbac Logo
A pharmaceutical company developing animal health solutions for vets, farmers, and pet owners worldwide.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin API for the international pharmaceutical industry.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V